EUVIMEDEUVIMED entdecken
Crossref

269 Risk vs. Reward: Long-Term Stimulant Therapy in Adults with ADHD

J. Vo, D. Vigilante, G. Yao, J. Dopheide

Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103295

DOI: 10.1016/j.japh.2026.103295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von J. Vo und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vo, J., Vigilante, D., Yao, G., & Dopheide, J. (2026). 269 Risk vs. Reward: Long-Term Stimulant Therapy in Adults with ADHD. Journal of the American Pharmacists Association, 66(4), 103295. https://doi.org/10.1016/j.japh.2026.103295

Vancouver

Vo J, Vigilante D, Yao G, Dopheide J. 269 Risk vs. Reward: Long-Term Stimulant Therapy in Adults with ADHD. Journal of the American Pharmacists Association. 2026;66(4):103295. doi:10.1016/j.japh.2026.103295

BibTeX
@article{Vo2026,
  author = {Vo, J. and Vigilante, D. and Yao, G. and Dopheide, J.},
  title = {269 Risk vs. Reward: Long-Term Stimulant Therapy in Adults with ADHD},
  journal = {Journal of the American Pharmacists Association},
  year = {2026},
  volume = {66},
  number = {4},
  pages = {103295},
  doi = {10.1016/j.japh.2026.103295}
}
Kostenlos starten →